Effect of serratus anterior plane block on stress response in patients undergoing thoracoscopic cardiac surgery of extracorporeal circulation

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022581

Enrollment

Unknown

Registered

2019-04-17

Start date

2019-04-20

Completion date

Unknown

Last updated

2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart disease

Interventions

Experimental group:Slowly injection 20 ml 0.5% ropivacaine by serratus anterior plane block

Control group:Injection 0.9%N.S.

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) ASA grade is grade III, aged 18-65 years old, height 150-180cm, BMI18-28kg/m2; (2) Thoracoscopic cardiac surgery was performed on an elective basis, and a chest drainage tube was placed after surgery; (3) Be able to correctly understand and evaluate the VAS score and the correct use of intravenous control analgesia pump; (4) The informed consent form of the experiment has been signed.

Exclusion criteria

Exclusion criteria: (1) Those with coagulopathy; (2) combined empyema and puncture site infection; (3) Those who are allergic to local anesthetic drugs (ropivacaine); (4) Unable to cooperate with the operator or communication difficulties; (5) Long-term chronic pain.

Design outcomes

Primary

Measure	Time frame
Cortisol;Epinephrine;Blood glucose;Interleukin 6;Interleukin 10;	—

Countries

China

Contacts

Public ContactXiong Meng-Ying

The First Affiliated Hospital of Nanchang University

545851485@qq.com+86 15970683610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026